Endonovo Therapeutics Introduces Support of SofPulse® With A New Ancillary Multi-Use Patient Brace From Protex
24 févr. 2020 13h00 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced the production and introduction of an ancillary multi-use...
Endonovo Therapeutics announces its collaboration with Major Universities for the Evaluation of SofPulse® for Orthopedic Surgeries
10 févr. 2020 07h30 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced their SofPulse® device is being evaluated at major...
Endonovo Therapeutics Announces First SofPulse® Sales to a Veterans Medical Center
27 janv. 2020 07h00 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 27, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced initial sales of SofPulse® units into a VA hospital in...
Endonovo Therapeutics Announces Reverse Stock Split - UPDATE
11 déc. 2019 13h40 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today it has determined to effect a 1-for-1,000 reverse stock...
Endonovo Therapeutics Reports Third Quarter 2019 Results
19 nov. 2019 16h35 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today its financial results for the quarter ended September 30,...
Endonovo Therapeutics Announces Partnership with Second Hospital
29 mars 2019 08h00 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA , March 29, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), today announced an agreement with a nationally recognized hospital group...
Endonovo Therapeutics Granted Trademarks for WoundPulse and OrthoHalo
22 mars 2019 08h00 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, March 22, 2019 (GLOBE NEWSWIRE) -- March 22, 2019 -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive...
Endonovo Therapeutics Issues Shareholder Letter and Update
11 janv. 2019 09h15 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic...
Endonovo Therapeutics Signs Distribution Agreement For National Distribution of Sofpulse® Electroceutical™ System
14 août 2018 09h25 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of Electroceutical™ Therapies, today...